📰 Isotope Processing News
Isotope Processing News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Isotope Processing. Real-time updates on events, politics, business and more.
April 3, 2023
NorthStar’s Mo-99 program continues at the forefront of U.S. radioisotope production as the only commercialized producer of key medical radioisotopes molybdenum-99 (Mo-99)/technetium-99m (Tc-99m
March 13, 2023
March 13, 2023 — Oak Ridge, TN — Balendra Sutharshan has been named chief operating officer for Oak Ridge National Laboratory. He will begin [...]
January 12, 2023
NorthStar Medical Radioisotopes Sets New Industry Precedent in Advancing Non-uranium based Commercial Production of Molybdenum-99 (Mo-99) - read this article along with other careers information, tips and advice on BioSpace
January 11, 2023
Proprietary electron accelerator technology achieves “two beams on target” milestone, validating proof of concept for large-scale U.S. Mo-99 production without the use of uranium
September 22, 2022
NorthStar is further expanding commercial-scale domestic radioisotope production capabilities using IBA’s environmentally preferable Rhodotron accelerator technology –
October 29, 2021
Marking Company’s progress in advancing innovative and environmentally sound production of diagnostic imaging and therapeutic radioisotopes for the United States and Wisconsin
May 13, 2021
NorthStar Medical Radioisotopes Receives Electron Beam Accelerators for First-of-its-Kind Advanced Medical Radioisotope Production. NorthStar, leading the way as the sole U.S. commercial supplier of molybdenum-99 (Mo-99), continues expansion efforts for increased capacity and ongoing reliable supply for diagnostic imaging − BELOIT, Wis.–(BUSINESS WIRE), 12 May 21, —NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharm...
January 7, 2021
Posted on 407 NorthStar Medical Radioisotopes, LLC, a global innovator in the production and distribution of radiopharmaceuticals used for medical imaging and therapeutic treatments, today announced that the U.S. Food and Drug Administration (FDA) has approved its application for producing Mo-99 from concentrated Mo-98 (cMo-98) and related software updates for the RadioGenix® System (technetium Tc 99m generator). Processing of cMo-9...